FALCONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 15.060
AS - Asia 8.125
EU - Europa 3.885
SA - Sud America 1.771
Continente sconosciuto - Info sul continente non disponibili 530
AF - Africa 335
OC - Oceania 26
Totale 29.732
Nazione #
US - Stati Uniti d'America 14.634
SG - Singapore 2.974
HK - Hong Kong 1.590
CN - Cina 1.569
BR - Brasile 1.398
IT - Italia 1.182
VN - Vietnam 703
BG - Bulgaria 515
SE - Svezia 471
DE - Germania 366
GB - Regno Unito 301
FR - Francia 271
IN - India 257
CA - Canada 250
RU - Federazione Russa 230
TR - Turchia 206
BD - Bangladesh 130
FI - Finlandia 130
JP - Giappone 130
AR - Argentina 107
IQ - Iraq 100
MX - Messico 69
CI - Costa d'Avorio 67
NL - Olanda 62
SA - Arabia Saudita 62
ZA - Sudafrica 62
VE - Venezuela 59
KR - Corea 53
PK - Pakistan 53
AT - Austria 50
EC - Ecuador 50
ES - Italia 48
PL - Polonia 47
CO - Colombia 44
ID - Indonesia 42
MA - Marocco 39
UA - Ucraina 35
PH - Filippine 34
CZ - Repubblica Ceca 32
KE - Kenya 32
UZ - Uzbekistan 31
CH - Svizzera 28
CL - Cile 28
SN - Senegal 28
PY - Paraguay 26
JO - Giordania 25
AE - Emirati Arabi Uniti 23
JM - Giamaica 23
TN - Tunisia 22
PE - Perù 21
UY - Uruguay 21
EG - Egitto 20
AU - Australia 19
IE - Irlanda 19
NG - Nigeria 16
NP - Nepal 16
TT - Trinidad e Tobago 15
AZ - Azerbaigian 14
HU - Ungheria 13
IL - Israele 12
MY - Malesia 12
BE - Belgio 11
DZ - Algeria 11
ET - Etiopia 11
AL - Albania 10
BO - Bolivia 10
GT - Guatemala 10
KZ - Kazakistan 10
CR - Costa Rica 9
HN - Honduras 9
LT - Lituania 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
IS - Islanda 8
OM - Oman 8
EU - Europa 7
GE - Georgia 7
LY - Libia 7
PA - Panama 7
AO - Angola 6
BB - Barbados 6
LB - Libano 6
NZ - Nuova Zelanda 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
BH - Bahrain 5
GR - Grecia 5
MD - Moldavia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
GY - Guiana 4
IR - Iran 4
KH - Cambogia 4
KW - Kuwait 4
NI - Nicaragua 4
TH - Thailandia 4
KG - Kirghizistan 3
RO - Romania 3
Totale 29.148
Città #
Singapore 1.728
Ashburn 1.681
Hong Kong 1.583
Dallas 1.538
Fairfield 1.208
San Jose 943
Santa Clara 925
Chandler 656
Shanghai 598
Woodbridge 555
Boulder 524
Seattle 518
Sofia 514
Houston 471
Wilmington 412
Cambridge 407
New York 389
Boardman 300
Los Angeles 269
Milan 265
Beijing 262
Princeton 231
Lawrence 215
Lauterbourg 199
Council Bluffs 194
Ho Chi Minh City 176
Des Moines 165
Ann Arbor 156
Medford 153
Istanbul 142
Hanoi 134
Ottawa 134
Florence 122
Munich 120
São Paulo 113
Tokyo 109
London 102
Redondo Beach 93
Frankfurt am Main 90
San Diego 88
Buffalo 84
Pisa 78
Abidjan 67
Helsinki 67
Rome 67
Dong Ket 62
Chicago 61
Serra 54
Bremen 52
Ogden 52
Rio de Janeiro 52
Columbus 50
Nanjing 47
Seoul 47
Hefei 46
Nuremberg 42
Baghdad 41
Turku 41
Belo Horizonte 40
Atlanta 37
Hyderabad 37
Brooklyn 35
The Dalles 35
Vienna 35
Warsaw 35
Denver 34
Stockholm 32
Brasília 31
Dakar 28
Nairobi 28
Orem 28
Pune 28
San Francisco 28
Tashkent 27
Brno 25
Dhaka 25
Haiphong 25
Hebei 25
Johannesburg 25
Toronto 25
Da Nang 24
Montreal 24
Phoenix 24
Redwood City 24
Curitiba 23
Riyadh 23
Nanchang 22
Amman 21
Fuzhou 21
Porto Alegre 21
Changsha 20
Tianjin 20
Jeddah 19
Manchester 19
Zurich 19
Chennai 18
Dearborn 18
Falls Church 18
Guayaquil 18
Lappeenranta 18
Totale 20.574
Nome #
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 243
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 230
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 226
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 225
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area 218
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 218
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 198
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 193
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 193
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 192
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization 190
What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains? 185
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019 184
A rare case of mycobacterial pseudoaneurysm of the superficial femoral artery 182
Therapeutic drug monitoring of antibiotics for methicillin-resistant Staphylococcus aureus infections: an updated narrative review for clinicians 178
Pharyngeal and cutaneous diphtheria: a tail of a refugee 177
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 175
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 174
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 171
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 161
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 159
Physical, Mental and Sexual Health Among Transgender Women. A comparative Study Among Operated Transgender and Cisgender Women in a National Tertiary Referral Network 156
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 154
Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia 154
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 149
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 149
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 147
High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis 146
Healthcare-associated pneumonia: a never-ending story 143
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study 143
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study 143
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 143
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 142
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy 142
Healthcare-associated pneumonia and multidrug-resistant bacteria: Do we have a convincing answer? 141
Clinical experience of anidulafungin for the treatment of patients with documented candidemia 140
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 140
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis 140
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 138
Candidaemia after heart valve replacement surgery: recurrence as prosthetic valve endocarditis is an expected over one-year complication 137
Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: An exploratory pilot study 137
The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis 136
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study 135
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 134
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 134
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 134
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia 133
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 131
Is NOX2 Upregulation Implicated in Myocardial Injury in Patients with Pneumonia? 131
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 131
Diabetes and acute bacterial skin and skin structure infections 130
Native-Valve Aspergillus Endocarditis: Case Report and Literature Review 129
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 129
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 129
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 129
Surveillance and management of multidrug-resistant microorganisms 128
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 128
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 127
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 127
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 127
Platelet activation is associated with myocardial infarction in patients with pneumonia 127
Pneumonia in frail older patients: An up to date 126
Candidal thrombophlebitis of central veins: case report and review 126
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 126
Cirrhotic patients are at risk for health care-associated bacterial infections 126
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial 126
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 125
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events 125
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections 125
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 125
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 124
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 124
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 123
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae 123
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 123
Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia 123
Performance status and in-hospital mortality of elderly patients with community acquired pneumonia 123
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 123
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 123
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 122
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 122
Paradigm Shift: Candida parapsilosis sensu stricto as the Most Prevalent Candida Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015–2022 Survey 122
Invasive aspergillosis in patients with liver disease 121
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature 121
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 121
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 120
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 119
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 119
Early identification of severe community-onset pneumonia in "frail elderly patient" 118
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 118
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection 118
Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification 118
Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing enterobacterales during a regional outbreak 118
Pretomanid for tuberculosis treatment: an update for clinical purposes 117
Management of COVID patients with convalescent plasma: Do we have the final word? 117
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections 116
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 116
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey 116
Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the Literature 116
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort 115
Totale 14.294
Categoria #
all - tutte 97.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.120 70 122 69 98 381 312 125 126 101 43 149 524
2022/20232.273 295 188 161 209 264 340 35 190 365 10 172 44
2023/20241.746 118 141 153 94 236 369 147 50 31 16 114 277
2024/20257.968 59 304 66 477 585 841 631 367 758 954 719 2.207
2025/20269.819 510 920 1.426 1.272 893 818 1.319 433 696 840 431 261
2026/2027549 549 0 0 0 0 0 0 0 0 0 0 0
Totale 29.732